ARIKAYCE (amikacin liposome inhalation suspension)
No Defense - 1
Credits
Agency Network | FCB Health Network |
Advertiser Brand | Insmed - ARIKAYCE, Bridgewater, NJ |
Entrant Company | Area 23, An FCB Health Network Company, New York |
Animation Company | Zombie Studio, São Paulo |
CCO | Tim Hawkey / Area 23, An FCB Health Network Company |
SVP, Group Creative Director | Chris Bernesby / Area 23, An FCB Health Network Company |
SVP, Creative Director | Joe Capanear / Area 23, An FCB Health Network Company |
VP, Creative Director | Mike McKeever / Area 23, An FCB Health Network Company |
VP, Associate Creative Director | Zuzana Zaloudek / Area 23, An FCB Health Network Company |
Group Art Supervisor | Olga Demeshchik / Area 23, An FCB Health Network Company |
Producer | Renee Jung / Area 23, An FCB Health Network Company |
SVP, Group Management Director | Robb Brady / Area 23, An FCB Health Network Company |
VP, Account Director | Martha Simpson / Area 23, An FCB Health Network Company |
Account Director | Jack O’Shaughnessy / Area 23, An FCB Health Network Company |
Strategic Planning Director | Greg Yellin / Area 23, An FCB Health Network Company |
CGI Design | Zombie Studios / Zombie Studios |
Typographer | Kevin Cantrell |
Typography Producer | Erik Attkisson |
This 2019 Clio Health Bronze winning entry titled 'No Defense - 1' was entered for ARIKAYCE (amikacin liposome inhalation suspension) by Area 23, An FCB Health Network Company, New York. The advertising agency is part of the agency network: FCB Health Network. The piece was submitted to the medium: Print & Out of Home Technique (Pharmaceutical) within the entry type: Direct-to-Professionals and the category: Art Direction.
Follow Us